SAVINO ANGELA MARIA

Capelletti, M., Montini, O., Ruini, E., Tettamanti, S., Savino, A., Sarno, J. (2025). Unlocking the Heterogeneity in Acute Leukaemia: Dissection of Clonal Architecture and Metabolic Properties for Clinical Interventions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(1) [10.3390/ijms26010045]. Detail

Saettini, F., Guerra, F., Mauri, M., Salter, C., Adam, M., Adams, D., et al. (2025). Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia. JOURNAL OF CLINICAL IMMUNOLOGY, 45(1) [10.1007/s10875-024-01793-8]. Detail

Savino, A., Stuani, L. (2024). Targeting glycolysis to rescue 2-hydroxyglutarate immunosuppressive effects in dendritic cells and acute myeloid leukemia. HAEMATOLOGICA, 109(3), 2388-2390 [10.3324/haematol.2023.284893]. Detail

Oikonomou, A., Watrin, T., Valsecchi, L., Scharov, K., Savino, A., Schliehe-Diecks, J., et al. (2024). Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening. HELIYON, 10(13) [10.1016/j.heliyon.2024.e34033]. Detail

Oikonomou, A., Valsecchi, L., Quadri, M., Watrin, T., Scharov, K., Procopio, S., et al. (2023). High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia. BIOCHEMICAL PHARMACOLOGY, 217(November 2023) [10.1016/j.bcp.2023.115809]. Detail